How to Store Research Peptides — GenoPept research guide (research use only)

How to Store Research Peptides: Shelf Life, Temperature and Stability Guide

Knowing how to store peptides is what separates a reproducible assay from an unexplained result. A lyophilised research peptide held cold, dry and dark is remarkably stable; the same molecule in aqueous solution at room temperature can lose measurable content within days. This guide explains the temperature windows for each physical form, the chemistry that drives degradation, and the handling controls that slow it — written for qualified researchers working with research-use-only material.

Updated ~13 min readReviewed by the GenoPept technical team

Key takeaways

  • Physical form decides everything: lyophilised powder is the stable state, solution is the perishable one.
  • Sealed lyophilised vials are typically held at −20 °C or below for long-term storage, at 2–8 °C for months of working stock, and tolerate short ambient excursions in transit.
  • Reconstituted solutions belong at 2–8 °C for near-term work and at −20 °C or colder, in single-use aliquots, for anything longer.
  • Five chemical routes dominate peptide degradation: deamidation of Asn/Gln, oxidation of Met/Cys/Trp/His, hydrolysis at labile bonds such as Asp-Pro, disulfide scrambling, and physical aggregation.
  • Repeated freezing and thawing is a distinct, avoidable stress — the ice–water interface and cryoconcentration drive aggregation independently of temperature alone.
  • Light, oxygen, humidity and container surface all matter: amber or foil-wrapped storage, minimal headspace and low-binding containers all reduce measurable loss.
  • Everything described here is for in-vitro laboratory research; nothing on this page is a dosing or administration instruction.

How should research peptides be stored?

Research peptides should be stored cold, dry, dark and sealed, with the exact temperature chosen from the physical form: sealed lyophilised vials at −20 °C or below for long-term holding, 2–8 °C for actively used stock, and reconstituted solutions at 2–8 °C for near-term work or frozen in single-use aliquots for longer. Every other control — light exclusion, low headspace, minimal handling — is secondary to getting the form-and-temperature pairing right.

The reason is kinetic rather than mysterious. Almost every degradation route available to a peptide requires water as a reactant, a solvent or a mobility medium. Freeze-drying removes bulk water and immobilises the peptide in an amorphous solid, and in that state the rate constants for hydrolysis, deamidation and aggregation fall by orders of magnitude. Wang’s review of solid protein pharmaceuticals sets out how residual moisture content, glass transition temperature and excipient selection govern the resulting solid-state shelf life.1

Lowering temperature does the same thing by a different mechanism. Chemical degradation rates in solution follow broadly Arrhenius behaviour, so moving a solution from 25 °C to 4 °C typically slows the dominant reactions several-fold, and moving to −20 °C slows them further still. The practical consequence is that storage temperature is the highest-leverage variable a researcher controls after the decision to keep material lyophilised.

This guide is a laboratory handling reference. It describes how to preserve the analytical integrity of material supplied for in-vitro research, and contains no instruction for administration to a person or animal.

Decision tree for how to store research peptides: lyophilised or reconstituted, then short-term or long-term, leading to ambient, 2 to 8 degrees, minus 20 degrees or minus 80 degrees storage Peptide storage decision tree Is the vial still sealed? Yes — lyophilised No — in solution Needed within weeks? Used up within days? 2–8 °C Yes — working stock. Keep dry, sealed and dark. −20 °C or below No — long-term. Desiccated. −80 °C for multi-year holds. 2–8 °C Yes — refrigerate, protect from light, do not freeze. Aliquot, then −20 °C No — split into single-use portions before first freeze. Every branch: keep sealed until needed, exclude light, never refreeze a thawed aliquot.
Figure 1. Storage decision tree for how to store peptides, branching on physical form and on how soon the material will be consumed.

Lyophilised vs reconstituted: two different problems

A sealed lyophilised vial and an open solution vial fail in different ways, so they need different controls. In the dry state the principal enemies are moisture ingress and temperature; in solution they are hydrolytic chemistry, oxidation, aggregation and microbial contamination.

Dry peptide is not inert. Residual water in a lyophilisate remains mobile enough to support slow solid-state chemistry, and the moisture content and glass transition temperature of the cake are the variables that govern how slow.1 That is precisely why lyophilised vials are stored sealed, cold and preferably with a desiccant in the storage box — condensation on a cold vial opened in a humid room can raise local moisture far above the level at which the material was validated.

In solution the picture changes entirely. Water is now the solvent, the peptide is mobile, and every reactive side chain is accessible. The dominant question becomes how long the material will spend in that state and at what temperature.

Why the “shelf life” number on a datasheet is a range, not a date

Peptide shelf life is sequence-dependent. A short, unmodified sequence with no Asn, Gln, Met, Cys or Trp — Epitalon’s Ala-Glu-Asp-Gly tetrapeptide, for example — has few chemical handles for degradation and is correspondingly robust. A long acylated GLP-1 analogue with multiple ionisable side chains and a strong tendency to self-associate is a different proposition. Published stability windows are therefore framed as typical ranges, with the batch certificate of analysis and any supplier-specific stability data taking precedence.

Storage temperatures and typical stability windows

The table below gives indicative windows widely used in peptide laboratories and reflected in supplier handling guidance. They are planning figures, not guarantees: the governing document for any particular batch is its certificate of analysis and any accompanying stability statement.

Table 1. Physical form × storage temperature → typical working stability window for research peptides
FormTemperatureTypical windowNotes
Lyophilised, sealed−80 °CSeveral yearsUsed for master stocks and reference standards; desiccated, minimal access
Lyophilised, sealed−20 °CAround 2 years, sequence-dependentThe standard long-term condition for most research peptides
Lyophilised, sealed2–8 °CMonthsConvenient for vials in active rotation; keep desiccated
Lyophilised, sealedAmbient (15–25 °C)Days to a few weeksTolerated as a transit excursion; not a storage condition
Reconstituted, preserved diluent2–8 °CDays to a few weeksCapped by the in-use limit for a preserved multi-draw container
Reconstituted, unpreserved diluent2–8 °CSingle session to a few daysNo microbial suppression; treat as a same-day preparation
Reconstituted, single-use aliquots−20 °CWeeks to monthsThaw once, use, discard; never re-freeze
Reconstituted, single-use aliquots−80 °CMonths and beyondPreferred for scarce or high-value material
Any formAbove 25 °CNot a storage conditionHydrolysis, deamidation and oxidation all accelerate sharply
Note. A frost-free domestic freezer is a poor choice for peptide storage. Automatic defrost works by cycling the cabinet above freezing, which subjects stored aliquots to repeated partial thaw events. A manual-defrost laboratory freezer, or a −80 °C unit, avoids this.

How peptides degrade: the five chemical routes

Peptide degradation is not a single process. Manning and colleagues’ review of protein pharmaceutical stability groups the routes into chemical instability — deamidation, oxidation, hydrolysis, disulfide exchange, beta-elimination — and physical instability, chiefly aggregation, precipitation and surface adsorption.2 Understanding which routes are open to a given sequence tells you which storage controls actually matter for it.

Peptide degradation pathways: deamidation of asparagine and glutamine, oxidation of methionine cysteine and tryptophan, hydrolysis at Asp-Pro bonds, disulfide scrambling and physical aggregation, each with the storage control that slows it Degradation pathways and the control that slows each Intact peptide Deamidation Asn, Gln Succinimide route → Asp / isoAsp Control: cold, dry, pH Oxidation Met, Cys, Trp, His O₂, peroxides, trace metals, light Control: dark, low O₂ Hydrolysis Asp-Pro, Asp-Gly Backbone cleavage, acid-catalysed Control: keep dry Disulfide exchange Cys-containing Scrambling and dimer formation Control: neutral-acid pH Physical: aggregation, precipitation, adsorption Driven by interfaces (air–liquid, ice–water), shaking, freeze–thaw and concentration. Often irreversible, and invisible until the solution hazes. Control: aliquot once, do not shake, use low-binding containers
Figure 2. The main peptide degradation pathways that peptide storage conditions are designed to suppress.

Deamidation

Deamidation converts an asparagine or glutamine side-chain amide into a carboxylate, usually via a cyclic succinimide intermediate that opens to a mixture of aspartate and isoaspartate. It is the classic non-enzymatic ageing reaction of peptides. Robinson and Robinson mapped deamidation rates across a large set of sequences and showed that the half-life depends steeply on the residue immediately following the Asn — Asn-Gly sequences are the fastest, with half-lives of days under some conditions, while sterically hindered neighbours extend them enormously.3 Deamidation is accelerated by higher pH, higher temperature and the presence of water, which is why cold, dry, near-neutral storage is the standard answer.

Oxidation

Oxidation targets methionine, cysteine, tryptophan and histidine. Li, Schöneich and Borchardt’s review sets out the mechanisms — direct reaction with dissolved oxygen and peroxides, metal-catalysed oxidation at histidine and methionine, and photo-oxidation of tryptophan — and the corresponding stabilisation strategies of oxygen exclusion, chelation of trace metals and light protection.4 In practice: fill headspace with an inert gas where the protocol allows it, store in the dark, and avoid buffers or plasticware that can leach peroxides.

Hydrolysis

Hydrolysis cleaves the backbone. Aspartyl residues are the usual weak point, and Oliyai and Borchardt characterised the pathways, kinetics and mechanism of aspartyl degradation in a model hexapeptide, showing pH-dependent partitioning between succinimide formation and direct cleavage.5 The Asp-Pro bond is particularly labile under acidic conditions and is a recognised hotspot in peptide mass spectrometry, where it produces characteristic fragmentation. Keeping material dry, and avoiding prolonged storage at low pH, addresses this route.

Disulfide exchange and aggregation

Cysteine-containing peptides can scramble their disulfide connectivity or form intermolecular dimers, especially at alkaline pH where the thiolate is populated. Aggregation, meanwhile, is a physical route driven by interfaces and concentration rather than by covalent chemistry, and Chi and colleagues’ analysis of non-native protein aggregation identifies partial unfolding at interfaces as the common initiating event.6 Aggregates are frequently irreversible and are the reason a hazy solution should not be rescued for quantitative work.

Sequence risk: which residues make a peptide fragile

You can predict most of a peptide’s storage risk by reading its sequence. The table below maps residues and motifs to the degradation route they open and the storage control that closes it.

Table 2. Sequence features, the degradation route they enable and the corresponding storage control
Feature in the sequenceRoute it opensAggravating conditionsPrimary control
Asn-Gly, Asn-SerRapid deamidation via succinimideAlkaline pH, warmth, waterStore dry and frozen; keep solutions near neutral and cold
Gln anywhereSlower deamidationWarmth, extended time in solutionMinimise time in solution
MetOxidation to sulfoxideDissolved O₂, peroxides, trace metalsLow headspace, dark, chelating buffer where compatible
Trp, TyrPhoto-oxidationUV and visible lightAmber vials or foil wrapping
Cys (free thiol)Oxidation and intermolecular dimer formationAlkaline pH, air exposureNeutral-to-slightly-acidic pH; inert headspace
Cys pairs (disulfide)Disulfide scramblingAlkaline pH, reducing agents, heatAvoid alkaline storage buffers
Asp-Pro, Asp-GlyBackbone hydrolysisAcidic pH, warmth, waterKeep lyophilised; avoid long acidic storage
N-terminal GlnCyclisation to pyroglutamateWarmth, time in solutionMinimise time in solution
High hydrophobicity, self-associatingAggregation and fibrillationInterfaces, shaking, freeze–thaw, concentrationAliquot once; never shake; low-binding containers
Acylated (fatty-acid) analoguesSelf-assembly and surface activityAir–liquid interface, agitationGentle handling; avoid foaming
Handling. Sequence risk is why a single “store at −20 °C” instruction cannot be applied uniformly. Where a batch certificate of analysis or supplier stability statement specifies different conditions for a particular compound, that document takes precedence over any general rule on this page.

Freezing, thawing and why you aliquot

Freezing a peptide solution is not simply “very cold storage”. The freezing transition itself is a stress event: as ice forms, solute concentrates into the shrinking liquid phase, pH can shift as buffer components crystallise out at different rates, and a large ice–water interface is created at which peptides can partially unfold. Thawing reverses the geometry but not the damage.

Systematic freeze–thaw characterisation work on protein therapeutics has shown that aggregation increases with the number of freeze–thaw transitions, and that freezing rate, container geometry and excipient composition all modulate the effect.7 Mechanistic work has continued to refine the role of the ice–water interface, but the practical conclusion is unchanged: reduce the number of transitions to one.

That is what aliquoting achieves. Dividing a freshly reconstituted stock into single-use portions before the first freeze means each portion experiences exactly one freeze and one thaw. The alternative — freezing one large vial and thawing it repeatedly — subjects the entire remaining stock to the stress each time.

Comparison of peptide storage strategies: one large frozen stock thawed repeatedly accumulates freeze-thaw stress, whereas single-use aliquots each experience one freeze and one thaw One big vial vs single-use aliquots Four experiments drawn from the same reconstituted stock Repeated thawing of one stock Stock 2 mL Thaw 1 · refreeze stress ×1 Thaw 2 · refreeze stress ×2 Thaw 3 · refreeze stress ×3 Thaw 4 stress ×4 Aliquot once, before the first freeze Stock 2 mL Aliquot A · 0.5 mL stress ×1 Aliquot B · 0.5 mL stress ×1 Aliquot C · 0.5 mL stress ×1 Aliquot D stress ×1 The same four experiments; the aliquoted route exposes the peptide to a quarter of the freeze–thaw stress and no re-freezing.
Figure 3. Why peptide storage protocols aliquot before freezing: single-use portions cap freeze–thaw stress at one transition each.
  1. Aliquot immediately after reconstitution. Divide while the solution is fresh, before any freezing has occurred.
  2. Size the aliquot to a single session. An aliquot that is only half used is an aliquot that will be re-frozen or discarded.
  3. Use low-binding tubes. Peptides adsorb to glass and polypropylene; low-binding consumables materially improve recovery, especially at low concentrations.
  4. Leave a small headspace. Solutions expand on freezing; a completely full tube can crack or unseat its cap.
  5. Freeze in a stable location. Manual-defrost freezer, away from the door, in a labelled rack rather than loose in a drawer.
  6. Thaw slowly and gently. On ice or at 2–8 °C, then invert gently to homogenise. Do not warm in the hand, in warm water or in a microwave, and do not vortex.
  7. Do not re-freeze. Use the thawed aliquot in that session and discard the remainder.

Light, oxygen, humidity and container effects

After temperature and physical form, four environmental variables account for most of the remaining variance in peptide stability: light, oxygen, humidity and the container surface itself.

Light drives photo-oxidation of tryptophan, tyrosine and, indirectly, methionine. Clear glass vials sitting on a bench under fluorescent lighting are a genuine, measurable exposure. Amber vials, foil wrapping or simply keeping vials in their carton addresses it at essentially zero cost.

Oxygen feeds oxidative routes. A vial with a large headspace and a rubber stopper that has been punctured several times contains air; where an assay is sensitive to oxidised species, overlaying with an inert gas before sealing is standard practice.

Humidity is the specific enemy of lyophilised material. Moisture picked up by a cake mobilises solid-state chemistry and can cause the cake to collapse. The commonest source is condensation from opening a cold vial in a warm, humid room, which is why every reconstitution protocol begins with equilibrating the sealed vial to room temperature.

Container surface causes silent loss. Cationic peptides adsorb rapidly and extensively to borosilicate glass and standard polypropylene; in one controlled study a large majority of peptide was lost from low-micromolar solutions within seconds of handling, with low-binding tubes substantially reducing the effect.8 This matters most for dilute working solutions, and it is a stability problem in every practical sense even though no bond has been broken.

Shipping, cold chain and what to do on receipt

Lyophilised peptides are shipped at ambient temperature as standard practice across the research supply industry, and this is a deliberate, defensible choice rather than a shortcut. In the dry, sealed state the material tolerates the days-long, moderate-temperature excursion of a courier network without meaningful loss, which is precisely the property that lyophilisation was adopted to provide.

What matters is what happens on arrival. A vial that has spent three days in a warm van and then sits on a desk for a fortnight has had a fortnight of avoidable ambient exposure, not three days.

  1. Inspect on arrival. Check that vials are intact, seals unbroken, caps in place, and that the cake looks like a cake — compact, white to off-white, not collapsed, sticky or discoloured.
  2. Reconcile against the paperwork. Match batch or lot numbers on the vials to the certificate of analysis. GenoPept publishes per-batch HPLC and mass spectrometry reports at /coa-certificates/.
  3. Move to storage promptly. Sealed lyophilised vials go straight to −20 °C or below unless they are going into immediate use.
  4. Log receipt. Date received, batch number, storage location and condition on arrival. This is the start of the chain of custody for any result generated from the material.
  5. Query anything anomalous before opening. A discoloured or collapsed cake is worth photographing and raising with the supplier while the vial is still sealed.

Frequently asked questions

Do research peptides need to be refrigerated?

Sealed lyophilised vials do not strictly require refrigeration for short periods and tolerate ambient transit, but refrigeration at 2–8 °C or freezing at −20 °C is strongly preferred for anything beyond a few weeks. Reconstituted solutions are different: they should be refrigerated at 2–8 °C as a matter of course, or frozen in single-use aliquots if they will not be consumed within days.

How long does a lyophilised peptide last in the freezer?

Sealed, desiccated lyophilised peptides held at −20 °C are commonly assigned working windows of around two years, and −80 °C storage extends this further. The precise figure is sequence-dependent — peptides rich in Asn, Gln, Met or Cys degrade faster than short unmodified sequences — so the batch certificate of analysis and any supplier stability statement should govern.

Can a peptide be re-frozen after thawing?

It should not be. Each freeze and thaw transition exposes the peptide to cryoconcentration, local pH shifts and a large ice–water interface, and studies of protein therapeutics show aggregation increasing with the number of transitions. The correct approach is to aliquot into single-use portions before the first freeze so that no portion is ever thawed twice.

Does a peptide solution need to be protected from light?

Yes, particularly for sequences containing tryptophan or tyrosine, which are directly photo-oxidised, and for those containing methionine, which can be oxidised indirectly. Amber vials, foil wrapping, or simply keeping vials in their carton in a dark refrigerator are all effective and cost nothing.

Why did my peptide arrive at room temperature?

Lyophilised peptides are shipped ambient as standard industry practice. In the dry sealed state the material is robust to the moderate temperature range and multi-day duration of a courier network, which is the entire point of freeze-drying. What matters is placing the vials into proper cold storage promptly after inspection on arrival.

What does a collapsed or discoloured cake mean?

A collapsed, sticky or glassy cake usually indicates moisture ingress or a temperature excursion that took the material above its glass transition temperature. Yellowing suggests oxidative or Maillard-type chemistry. Either finding is a reason to photograph the sealed vial and raise it with the supplier against the batch record rather than proceeding to reconstitution.

Is a domestic frost-free freezer suitable for peptide storage?

No. Frost-free operation works by periodically warming the cabinet above freezing to sublime accumulated ice, which subjects stored aliquots to repeated partial thaw events — exactly the stress aliquoting is designed to avoid. A manual-defrost laboratory freezer or a −80 °C ultra-low freezer is the appropriate equipment.

Which peptides are most fragile in storage?

Those with reactive side chains and self-associating character. Sequences containing Asn-Gly or Asn-Ser motifs deamidate quickly; methionine, cysteine and tryptophan invite oxidation; Asp-Pro bonds hydrolyse readily; and long, hydrophobic or fatty-acid-acylated analogues aggregate at interfaces. Short unmodified sequences without those features are generally the most robust.

References

  1. Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics. 2000;203(1–2):1–60. PubMed
  2. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010;27(4):544–575. PubMed
  3. Robinson NE, Robinson AB. Molecular clocks. Proceedings of the National Academy of Sciences. 2001;98(3):944–949. PubMed
  4. Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnology and Bioengineering. 1995;48(5):490–500. PubMed
  5. Oliyai C, Borchardt RT. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide. Pharmaceutical Research. 1993. PubMed
  6. Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharmaceutical Research. 2003;20(9):1325–1336. PubMed
  7. Jain K, Salamat-Miller N, Taylor K. Freeze–thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics. Scientific Reports. 2021;11:11332. PubMed
  8. Kristensen K, Henriksen JR, Andresen TL. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLOS ONE. 2015;10(5):e0122419. PLOS ONE

Research-grade peptides, batch-verified

GenoPept supplies lyophilised research peptides with a per-batch third-party certificate of analysis covering HPLC purity and mass spectrometry identity, dispatched from the UK, strictly for laboratory research.

Browse the store See COA certificates

Research use only. All products described on this page are supplied strictly for in-vitro laboratory research and analytical purposes. They are not medicines, are not for human or veterinary use, and must not be used for diagnosis, treatment, cure or prevention of any disease or condition. Nothing on this page is medical, legal or dosing advice. Purchasers must be qualified researchers or institutions and must comply with all applicable laws. See our Research Use Only policy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
WhatsApp us